Cargando…

Impact of the UK lockdown on people at risk of COPD

Impact of the UK lockdown on early COPD https://bit.ly/3laMsmi

Detalles Bibliográficos
Autores principales:	Donaldson, Gavin C., Ritchie, Andrew I., Calverley, Peter M.A., Vestbo, Jorgen, Fageras, Malin, de la Hoz, Alberto, Bucchioni, Enrica, Compton, Chris H., Mezzi, Karen, Wedzicha, Jadwiga A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607069/ https://www.ncbi.nlm.nih.gov/pubmed/34820444 http://dx.doi.org/10.1183/23120541.00358-2021

Ejemplares similares

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Deprivation, winter season, and COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2013)

The causes and consequences of seasonal variation in COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2014)

Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study
por: James, Gareth Dean Russell, et al.
Publicado: (2013)

Roflumilast: a review of its use in the treatment of COPD
por: Wedzicha, Jadwiga A, et al.
Publicado: (2016)

Trends in management and outcomes of COPD patients in primary care, 2000–2009: a retrospective cohort study
por: James, Gareth D, et al.
Publicado: (2014)

The role of complement activation in COPD exacerbation recovery
por: Westwood, John-Paul, et al.
Publicado: (2016)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
por: Calverley, Peter M, et al.
Publicado: (2016)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
por: Eriksson, Göran, et al.
Publicado: (2017)

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
por: Miravitlles, Marc, et al.
Publicado: (2022)

Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study
por: Anzueto, Antonio R., et al.
Publicado: (2018)

Community-based recruitment of patients with COPD into clinical research
por: Brill, Simon E, et al.
Publicado: (2014)

The severity of airways obstruction as a determinant of treatment response in COPD
por: Calverley, Peter MA, et al.
Publicado: (2006)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Is gastro-oesophageal reflux associated with COPD exacerbations?
por: Wedzicha, Jadwiga A.
Publicado: (2013)

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
por: Singh, Dave, et al.
Publicado: (2020)

Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study
por: Wedzicha, Jadwiga A., et al.
Publicado: (2019)

Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
por: Wedzicha, Jadwiga A., et al.
Publicado: (2016)

Meeting the GOLD Standard: COPD Treatment in the UK Today
por: Calverley, P.M.A.
Publicado: (2019)

Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD
por: Wilkinson, Tom M.A., et al.
Publicado: (2006)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

COPD exacerbations: defining their cause and prevention
por: Wedzicha, Jadwiga A, et al.
Publicado: (2007)

First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis
por: Price, David, et al.
Publicado: (2016)

Bacteria and sputum inflammatory cell counts; a COPD cohort analysis
por: Beech, Augusta S., et al.
Publicado: (2020)

Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
por: Donaldson, Gavin C., et al.
Publicado: (2005)

Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
por: Choudhury, Aklak B, et al.
Publicado: (2007)

Influence of weather and atmospheric pollution on physical activity in patients with COPD
por: Alahmari, Ayedh D., et al.
Publicado: (2015)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

Prevention of COPD exacerbations: medications and other controversies
por: Vestbo, Jørgen, et al.
Publicado: (2015)

Inhaled corticosteroids reduce senescence in endothelial progenitor cells from patients with COPD
por: Paschalaki, Koralia, et al.
Publicado: (2022)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset
por: Calverley, Peter M A, et al.
Publicado: (2022)

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
por: Halpin, David M.G., et al.
Publicado: (2021)

Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial
por: Brill, Simon E, et al.
Publicado: (2015)

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change
por: Jones, Paul W, et al.
Publicado: (2011)

Exacerbation rate, health status and mortality in COPD – a review of potential interventions
por: Seemungal, Terence AR, et al.
Publicado: (2009)

Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis
por: Bafadhel, Mona, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n1fn39fb55uuau7vhtb7f897al